◀ Back to MTOR
HSP90AA1 — MTOR
Pathways - manually collected, often from reviews:
-
NCI Pathway Database Regulation of Telomerase:
Telomerase complex (TERT-PTGES3)
→
Telomerase/AKT1/mTOR/p70S6K complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT-PTGES3-DKC1)
(modification, collaborate)
Haendeler et al., FEBS Lett 2003
Evidence: assay
-
NCI Pathway Database Regulation of Telomerase:
Telomerase/AKT1/mTOR/p70S6K complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT-PTGES3-DKC1)
→
AKT1 (AKT1)
(modification, collaborate)
Haendeler et al., FEBS Lett 2003
Evidence: assay
-
NCI Pathway Database Regulation of Telomerase:
Telomerase/AKT1/mTOR/p70S6K complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT-PTGES3-DKC1)
→
p70S6K (RPS6KB1)
(modification, collaborate)
Haendeler et al., FEBS Lett 2003
Evidence: assay
-
NCI Pathway Database Regulation of Telomerase:
Telomerase/AKT1/mTOR/p70S6K complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT-PTGES3-DKC1)
→
mTOR (MTOR)
(modification, collaborate)
Haendeler et al., FEBS Lett 2003
Evidence: assay
-
NCI Pathway Database IL2 signaling events mediated by PI3K:
TERT (TERT)
→
AKT1/mTOR/p70S6K/Hsp90/TERT complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2 signaling events mediated by PI3K:
Hsp90 (HSP90AA1)
→
AKT1/mTOR/p70S6K/Hsp90/TERT complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2 signaling events mediated by PI3K:
Hsp90 (HSP90AA1)
→
mTOR (MTOR)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2 signaling events mediated by PI3K:
AKT1 (AKT1)
→
AKT1/mTOR/p70S6K/Hsp90/TERT complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2 signaling events mediated by PI3K:
AKT1/mTOR/p70S6K/Hsp90/TERT complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT)
→
mTOR (MTOR)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
-
NCI Pathway Database IL2 signaling events mediated by PI3K:
AKT1/mTOR/p70S6K/Hsp90/TERT complex (AKT1-MTOR-RPS6KB1-HSP90AA1-TERT)
→
p70S6K (RPS6KB1)
(modification, collaborate)
Kawauchi et al., J Immunol 2005
Evidence: mutant phenotype, assay, physical interaction
Text-mined interactions from Literome
Shimamura et al., Cancer Res 2008
(Adenocarcinoma...) :
In contrast,
Hsp90 inhibition overcomes these limitations in vitro and depletes cells of EGFR, other RTKs, and phospho-Akt and
inhibits mTOR signaling whether or not T790M is present
Gazitt et al., Int J Oncol 2009
(Bone Neoplasms...) :
We used 17-AAG to inhibit
Hsp90 and rapamycin to
inhibit mTOR , in the osteosarcoma cell lines, HOS and KHOS/NP
Surova et al., FiziolohichnyÄ zhurnal (Kiev, Ukraine : 1994) 2009
:
The changes of mRNA levels of genes of heat shock proteins HSP70 and
HSP90 , antiapoptotic protein Bcl2 and key
regulator of autophagy
FRAP in cardiomyocytes culture were established
Delgoffe et al., Mol Immunol 2009
:
Enhanced interaction between
Hsp90 and raptor
regulates mTOR signaling upon T cell activation